Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

Condition:   Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Placebo;   Procedure: Digital mammography;   Other: immunohistochemistry staining method;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Genetic: protein expression analysis;   Other: pharmacogenomic studies;   Other: questionnaire administration;   Procedure: Fine needle aspiration;   Other: Quality of Life AssessmentSponsors:   City of Hope Medical Center;   National Cancer Institute (NCI);   St. Jude Children's Research Hospital;   University Health Network, Toronto;   University of Michigan;   Dana-Farber Cancer Institute;   Mayo Clinic;   University of WashingtonRecruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials